PHSA 18560
Solicitation number BCPHSA_18560
Publication date
Closing date and time 2026/02/02 17:00 EST
Description
Issued: January 22, 2026
File # PHSA 18560
NOI Title: Medtronic's Symplicity SpyralTM Renal Denervation (RDN) System
Provincial Health Services Authority
Notice is hereby given that Vancouver Coastal Health Authority (the “Health Authority”), through their collective agent Provincial Health Services Authority (“PHSA”), intends to directly award a Contract to the following supplier to provide Symplicity SpyralTM Renal Denervation (RDN) System and Symplicity Spyral™ multi-electrode RDN catheter for Vancouver General Hospital at an estimated value of $ 288,000.00 CAD (excluding taxes) for a term of two (2) years with one (1) option for extension of two (2) years. This Notice may be extended to other facilities and Health Authorities in British Columbia at the same pricing structure to acquire the technology within the term of the agreement.
Medtronic Canada ULC 99 Hereford Street, Brampton, ON L6Y0R3, Canada.
In accordance with applicable trade agreements, PHSA, as agent for the Health Authorities has chosen not to proceed with a competitive process for the following reason:
the goods can be supplied only by the selected supplier and no alternative or substitute exists due to an absence of competition for technical reasons.
The Symplicity Spyral RDN System is designed to deliver radiofrequency (RF) energy, via the Symplicity SpyralTM multi-electrode renal denervation catheter, through the wall of the renal artery to achieve renal denervation. The procedure safely disrupts the overactive sympathetic signaling between the kidneys and brain, to reduce blood pressure. This is the only system allows for denervation throughout the renal anatomy, including the distal branches, where late arriving nerves are accessible and total nerve density is highest.
The only Renal Denervation product in the market is Medtronic Canada ULC’s Symplicity SpyralTM Renal Denervation (RDN) System which is Health Canada approved.
Vendors who wish to challenge this decision should submit a detailed written objection for the attention of Arman Uddin, Buyer – Cardiac Care by email to arman.uddin@phsa.ca before 2:00pm Pacific Time, February 02, 2026. PHSA will review all issues received by this date and provide due consideration to each objection.
Please Reference File: # PHSA 18560 on all written correspondence.
Harshwardhan Naik Buyer – Cardiac care
Provincial Health Services Authority
1795 Willingdon Avenue,
Burnaby, BC V5C 6E3 Email: Harshwardhan.naik@phsa.ca
Web: www.phsa.ca
File # PHSA 18560
NOI Title: Medtronic's Symplicity SpyralTM Renal Denervation (RDN) System
Provincial Health Services Authority
Notice is hereby given that Vancouver Coastal Health Authority (the “Health Authority”), through their collective agent Provincial Health Services Authority (“PHSA”), intends to directly award a Contract to the following supplier to provide Symplicity SpyralTM Renal Denervation (RDN) System and Symplicity Spyral™ multi-electrode RDN catheter for Vancouver General Hospital at an estimated value of $ 288,000.00 CAD (excluding taxes) for a term of two (2) years with one (1) option for extension of two (2) years. This Notice may be extended to other facilities and Health Authorities in British Columbia at the same pricing structure to acquire the technology within the term of the agreement.
Medtronic Canada ULC 99 Hereford Street, Brampton, ON L6Y0R3, Canada.
In accordance with applicable trade agreements, PHSA, as agent for the Health Authorities has chosen not to proceed with a competitive process for the following reason:
the goods can be supplied only by the selected supplier and no alternative or substitute exists due to an absence of competition for technical reasons.
The Symplicity Spyral RDN System is designed to deliver radiofrequency (RF) energy, via the Symplicity SpyralTM multi-electrode renal denervation catheter, through the wall of the renal artery to achieve renal denervation. The procedure safely disrupts the overactive sympathetic signaling between the kidneys and brain, to reduce blood pressure. This is the only system allows for denervation throughout the renal anatomy, including the distal branches, where late arriving nerves are accessible and total nerve density is highest.
The only Renal Denervation product in the market is Medtronic Canada ULC’s Symplicity SpyralTM Renal Denervation (RDN) System which is Health Canada approved.
Vendors who wish to challenge this decision should submit a detailed written objection for the attention of Arman Uddin, Buyer – Cardiac Care by email to arman.uddin@phsa.ca before 2:00pm Pacific Time, February 02, 2026. PHSA will review all issues received by this date and provide due consideration to each objection.
Please Reference File: # PHSA 18560 on all written correspondence.
Harshwardhan Naik Buyer – Cardiac care
Provincial Health Services Authority
1795 Willingdon Avenue,
Burnaby, BC V5C 6E3 Email: Harshwardhan.naik@phsa.ca
Web: www.phsa.ca
Contract duration
Refer to the description above for full details.
Trade agreements
-
Please refer to tender description or tender documents
Contact information
Contracting organization
- Organization
-
Providence Health Care
- Address
-
1795 Willingdon AveBurnaby, British Columbia, V5C 6E3Canada
- Email
- arman.uddin@phsa.ca
- Address
-
1795 Willingdon AveBurnaby, British Columbia, V5C 6E3Canada
Bidding details
Full details for this tender opportunity are available on a third-party site
Click on the button below to be directed to this website. Note that on the third-party site you may need an account to view and/or bid on this tender. Information on any fees or additional costs to access the full details is outlined in the Description tab of this tender opportunity.